To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

A novel complex neurologi… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

A novel complex neurological phenotype due to a homozygous mutation in FDX2

Journal article
Authors J. Gurgel-Giannetti
D. S. Lynch
A. R. B. de Paiva
L. T. Lucato
G. Yamamoto
Christer Thomsen
S. Basu
F. Freua
A. V. Giannetti
B. D. de Assis
M. D. Ribeiro
I. Barcelos
K. S. Souza
F. Monti
U. S. Melo
S. Amorim
L. G. L. Silva
L. I. Macedo-Souza
A. M. Vianna-Morgante
M. Hirano
M. S. Van der Knaap
R. Lill
M. Vainzof
Anders Oldfors
H. Houlden
F. Kok
Published in Brain
Volume 141
Pages 2289-2298
ISSN 0006-8950
Publication year 2018
Published at Institute of Biomedicine, Department of Pathology
Pages 2289-2298
Language en
Keywords FDX2, brain, nerve, muscle, optic atrophy, sulfur protein biogenesis, fe-s cluster, mitochondrial myopathy, i, deficiency, biosynthesis, spectrum, diseases, roles, nubpl, gene
Subject categories Neurosciences


Defects in iron-sulphur [Fe-S] cluster biogenesis are increasingly recognized as causing neurological disease. Mutations in a number of genes that encode proteins involved in mitochondrial [Fe-S] protein assembly lead to complex neurological phenotypes. One class of proteins essential in the early cluster assembly are ferredoxins. FDX2 is ubiquitously expressed and is essential in the de novo formation of [2Fe-2S] clusters in humans. We describe and genetically define a novel complex neurological syndrome identified in two Brazilian families, with a novel homozygous mutation in FDX2. Patients were clinically evaluated, underwent MRI, nerve conduction studies, EMG and muscle biopsy. To define the genetic aetiology, a combination of homozygosity mapping and whole exome sequencing was performed. We identified six patients from two apparently unrelated families with autosomal recessive inheritance of a complex neurological phenotype involving optic atrophy and nystagmus developing by age 3, followed by myopathy and recurrent episodes of cramps, myalgia and muscle weakness in the first or second decade of life. Sensory-motor axonal neuropathy led to progressive distal weakness. MRI disclosed a reversible or partially reversible leukoencephalopathy. Muscle biopsy demonstrated an unusual pattern of regional succinate dehydrogenase and cytochrome c oxidase deficiency with iron accumulation. The phenotype was mapped in both families to the same homozygous missense mutation in FDX2 (c. 431C > T, p. P144L). The deleterious effect of the mutation was validated by real-time reverse transcription polymerase chain reaction and western blot analysis, which demonstrated normal expression of FDX2 mRNA but severely reduced expression of FDX2 protein in muscle tissue. This study describes a novel complex neurological phenotype with unusual MRI and muscle biopsy features, conclusively mapped to a mutation in FDX2, which encodes a ubiquitously expressed mitochondrial ferredoxin essential for early [Fe-S] cluster biogenesis.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?